Researchers are describing the results of a recent clinical trial — a breakthrough in glioblastoma treatment with the help of a modified cold virus injected directly into the tumor. When combined with an immunotherapy drug, the authors observed a subset of patients that appeared to be living longer as a result of this therapy.
Breakthrough in glioblastoma treatment with the help of a virus
